Form 8-K - Current report:
SEC Accession No. 0001193125-26-108439
Filing Date
2026-03-16
Accepted
2026-03-16 16:30:39
Documents
11
Period of Report
2026-03-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d55950d8k.htm   iXBRL 8-K 22791
  Complete submission text file 0001193125-26-108439.txt   132678

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20260313.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20260313_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20260313_pre.xml EX-101.PRE 10821
15 EXTRACTED XBRL INSTANCE DOCUMENT d55950d8k_htm.xml XML 3532
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 26757258
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)